Addressing patient-related challenges in the pharmaceutical supply chain

Syneos Health’s Kim Plesnarski reveals the key issues customers are currently trying to address, including the shift in retail from small molecule products to biologics.

Study: Association between anxiety and depression treatments and heart disease outcomes

The researchers aimed to determine the impact of psychotherapeutic or psychopharmacological treatments on adverse outcomes in individuals with coronary artery disease or heart failure.

Bird flu infected after contact with cows in Texas

The cases add another worrying wrinkle to a global pandemic that has devastated bird and marine mammal populations and recently appeared in cattle herds.

Bayer names Sue Ann Pentecost as vice president and head of U.S. pharmaceutical communications

Bayer has announced Sue Ann Pentecost as its new vice president and head of pharmaceutical communications for the United States. She will report directly to Beth Roden, Senior Vice President and Director of Communications for Bayer US and Director of Communications for Bayer Consumer Health NA. Mr. Pentecost will succeed Lori Moore, who will retire at the end of May.

InCrowd Inc on LinkedIn:

Harness the power of pharmaceuticals to fight physician burnout! Check out this new article in Pharmaceutical Executive by Daniel S. Fitzgerald, CEO and President of Apollo Intelligence. #Healthcare market research
https://lnkd.in/ezJS64x6

Have news you’d like to share on Pharma Pulse? Contact Social Media Editor Miranda Schmalfus